PFSA Stock Analysis: Buy, Sell, or Hold?
PFSA - Profusa, Inc. Common Stock
$0.24
0.01 (5.40%)
β²
5d:
-19.9%
30d:
-44.98%
90d:
-73.1%
WAIT
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Get Alerted When PFSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: PFSA is down 19.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: PFSA is down 19.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PFSA is currently trading at $0.24, which is considered oversold relative to its 30-day fair value range of $0.30 to $0.47.
Technical Outlook: Technically, PFSA is in a strong downtrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PFSA is in a strong downtrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.30 -
$0.47
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- WARNING: Recommendation downgraded due to -19.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.30 -
$0.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.39
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Share & Embed Analysis
Last updated: June 15, 2026 4:33 PM ET
Data refreshes hourly during market hours. Next update: 5:33 PM
Data refreshes hourly during market hours. Next update: 5:33 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 53 HOLD |